Ptc Therapeutics (PTCT) Revenue (2012 - 2026)
Ptc Therapeutics' quarterly Revenue came in at $272.6 million in Q1 2026, down 76.83% year-on-year from $1.2 billion in Q1 2025, and up 65.51% quarter-over-quarter from $164.7 million in Q4 2025.
Ptc Therapeutics has reported Revenue for 15 years, with the latest figure at $272.6 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 76.83% year-over-year to $272.6 million; the trailing twelve-month figure through Mar 2026 stood at $827.1 million (down 47.85% YoY), and the FY2025 full-year result was $1.7 billion, up 114.51% from the prior year.
- Revenue for Q1 2026 stood at $272.6 million, up from $164.7 million in the prior quarter.
- The five-year high for Revenue was $1.2 billion in Q1 2025, with the low at $148.7 million in Q1 2022.
- Average Revenue over 5 years is $266.2 million, with a median of $210.6 million recorded in 2024.
- Year-over-year, Revenue surged 459.73% in 2025 and plunged 76.83% in 2026.
- Tracing PTCT's Revenue over 5 years: stood at $167.4 million in 2022, then jumped by 83.41% to $307.1 million in 2023, then slumped by 30.58% to $213.2 million in 2024, then slipped by 22.75% to $164.7 million in 2025, then surged by 65.51% to $272.6 million in 2026.
- The last three Revenue figures came in at $272.6 million (Q1 2026), $164.7 million (Q4 2025), and $211.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Ptc Therapeutics | 6.09 Bn | 4.20 Bn | 244.52 Mn | 272.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272.55 Mn |
| Dec 31, 2025 | 164.68 Mn |
| Sep 30, 2025 | 211.01 Mn |
| Jun 30, 2025 | 178.88 Mn |
| Mar 31, 2025 | 1.18 Bn |
| Dec 31, 2024 | 213.17 Mn |
| Sep 30, 2024 | 196.79 Mn |
| Mar 31, 2024 | 210.12 Mn |
| Dec 31, 2023 | 307.06 Mn |
| Sep 30, 2023 | 196.58 Mn |
| Jun 30, 2023 | 213.81 Mn |
| Mar 31, 2023 | 220.38 Mn |
| Dec 31, 2022 | 167.41 Mn |
| Sep 30, 2022 | 217.13 Mn |
| Jun 30, 2022 | 165.53 Mn |
| Mar 31, 2022 | 148.74 Mn |
| Dec 31, 2021 | 165.23 Mn |
| Sep 30, 2021 | 138.74 Mn |
| Jun 30, 2021 | 116.68 Mn |
| Mar 31, 2021 | 117.94 Mn |
| Dec 31, 2020 | 4.09 Mn |
| Sep 30, 2020 | 118.40 Mn |
| Jun 30, 2020 | 75.24 Mn |
| Mar 31, 2020 | 68.26 Mn |
| Dec 31, 2019 | 81.41 Mn |
| Sep 30, 2019 | 71.37 Mn |
| Jun 30, 2019 | 85.48 Mn |
| Mar 31, 2019 | 53.05 Mn |
| Dec 31, 2018 | 85.83 Mn |
| Sep 30, 2018 | 570,000.00 |
| Jun 30, 2018 | 573,000.00 |
| Mar 31, 2018 | 55.98 Mn |
| Dec 31, 2017 | 57.95 Mn |
| Sep 30, 2017 | 41.78 Mn |
| Jun 30, 2017 | 47.89 Mn |
| Mar 31, 2017 | 26.44 Mn |
| Dec 31, 2016 | 25.12 Mn |
| Sep 30, 2016 | 22.01 Mn |
| Jun 30, 2016 | 15.44 Mn |
| Mar 31, 2016 | 18.88 Mn |
| Dec 31, 2015 | 12.73 Mn |
| Sep 30, 2015 | 9.78 Mn |
| Jun 30, 2015 | 6.77 Mn |
| Mar 31, 2015 | 7.48 Mn |
| Dec 31, 2014 | 24.02 Mn |
| Sep 30, 2014 | 1.69 Mn |
| Jun 30, 2014 | 1.68 Mn |
| Mar 31, 2014 | 70,000.00 |
| Dec 31, 2013 | 4.41 Mn |
| Sep 30, 2013 | 834,000.00 |
| Jun 30, 2013 | 5.87 Mn |
| Mar 31, 2013 | 6.07 Mn |
| Dec 31, 2012 | 6.64 Mn |
| Sep 30, 2012 | 7.20 Mn |
| Jun 30, 2012 | 7.59 Mn |